Immuneering CorporationIMRXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+5.1%
5Y CAGR+22.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+5.1%/yr
Annual compound
5Y CAGR
+22.9%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $42.05M | -12.3% |
| 2024 | $47.96M | +15.2% |
| 2023 | $41.62M | +14.8% |
| 2022 | $36.27M | +36.6% |
| 2021 | $26.54M | +76.9% |
| 2020 | $15.00M | +250.6% |
| 2019 | $4.28M | - |